Deal overview
| Target | ALLERGAN PLC |
|---|---|
| Bidder | ABBVIE INC |
| Price | £0.00 Full version or £25.00 Light version |
| Publication Date | Jun 25, 2019 |
| Abstract | On 25 June 2019, the US-based pharmaceutical company AbbVie Inc ("AbbVie") announced that it had agreed to acquire Allergan plc ("Allergan"), an Irish company listed on the New York Stock Exchange, through a scheme of arrangement. The cash and stock transaction valued each Allergan share at $188.24 and represented an equity value of approximately $63 billion. It was expected ... |
| Number of pages (Full version) | 0 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2024 M&A Monitor Limited
